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Mechanisms of Very Late Stent Thrombosis
After Drug-Eluting Stent Implantation
Findings From Coronary Angioscopy and Optical Coherence Tomography
Hiroki Ikenaga, MD, Masaharu Ishihara, MD, PHD, Kazuoki Dai, MD,
Yasuharu Nakama, MD, Takayuki Ohtani, MD
DRUG-ELUT ING STENTS (DES ) ARE NOW WIDELY USED FOR PAT IENTS
WITH CORONARY ARTERY DI SEASE UNDERGOING PERCUTANEOUS COR -
ONARY INTERVENT IONS . A current major concern of using DES is very late stent thrombosis
(VLST) that may occur beyond 1 year after DES implantation (1). VLST is an infrequent, albeit
catastrophic complication, which can lead to myocardial infarction or sudden cardiac death (2).
However, the underlying mechanisms of VLST remain unclear. In the current report, we show 3 cases
of VLST after sirolimus-eluting stent (SES) implantation. Findings from coronary angioscopy (CAS) and
optical coherence tomography (OCT) suggested 3 differential mechanisms of VLST in each case.
In the ﬁrst case (Fig. 1), CAS and OCT showed uncovered and malapposed stent struts at the culprit
lesion. Late stent malapposition is caused by stent underexpansion and thrombus resolution or by
positive vessel remodeling. The later mechanism is characteristic of DES (3). In this case, CAS ﬁndings
revealed yellow plaque, which might reﬂect inﬂammatory reaction. Delayed neointimal coverage over
stent struts and late stent malapposition are ordinarily thought to be associated with VLST in patients
treated with DES.
In the second case (Fig. 2), coronary rupture was observed in the yellow plaque which completely
covered stent struts. Rupture of thin-cap ﬁbroatheroma is a common cause of acute coronary syndrome.
It has been reported that neointimal atherosclerotic change (neoatherosclerosis) occurred with DES
earlier than with a bare-metal stent; and unstable features of neoatherosclerosis were identiﬁed after
shorter implantation duration then with DES (4). Enhanced inﬂammation after DES implantation may
promote atherosclerosis and exaggerate vulnerability of the plaque.
In the third case (Fig. 3), ruptured plaque was observed under the stent struts. The rupture continued
to a large cavity behind the completely covered stent struts. To our knowledge, this is the ﬁrst report
of such a case. This is likely associated with delayed arterial healing following DES implantation in a
patient with acute myocardial infarction (AMI). The underlying plaque in this patient might have been
lipid-rich necrotic plaque, which was not covered by thick neointima following stent implantation
because of the drug effect. This may have created another thin-cap ﬁbroatheroma, which ﬁnally
ruptured.
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1218Figure 1. Uncovered and Malapposed Stent Struts
A 70-year-old man underwent a 2.5 mm  28 mm sirolimus-eluting stent (SES) implantation in the mid-left anterior descending artery (LAD) for acute myocar-
dial infarction (AMI). Aspirin (100 mg/day) with clopidogrel (75 mg/day) was prescribed, but clopidogrel was stopped because of drug-induced liver injury 1
month after SES implantation. Thirty-four months after SES implantation, the patient suddenly suffered from recurrence of angina and was admitted to our hos-
pital. Emergent coronary angiography (CAG) showed thrombus-like shadow in SES (A). After aspiration thrombectomy (B), optical coherence tomography (OCT)
and coronary angioscopy (CAS) were performed. OCT and CAS revealed no coverage of neointima over stent struts in the distal and proximal portion of stent
(a). At thrombus sites, OCT revealed malapposition and red and white thrombus on the stent struts which were not covered by neointima (b, c and d). CAS
revealed malapposition and yellow plaque under stent struts (b, c and d, yellow arrow).Figure 2. In-Stent Restenosis With Neoatherosclerosis
A 68-year-old man underwent 2 SES implantations in the mid-LAD for AMI (2.5 mm  18 mm and 2.5 mm  18 mm). Aspirin (100 mg/day) with ticlopidine (200
mg/day) was prescribed. Aspirin and ticlopidine were stopped 1 year after SES implantation by a self-judgment. Fifty-four months after SES implantation, the
patient suddenly suffered from recurrence of angina on exertion and was admitted to our hospital. Emergent CAG revealed total occlusion at proximal SES in
the mid LAD (A). After balloon angioplasty (B), OCT and CAS were performed. OCT and CAS revealed neointimal coverage over stent in the distal and proximal
portion of stent (a). OCT revealed cavity formation (white arrow) over stent struts (b, c). CAS revealed yellow plaque rupture (C, yellow arrow) and cavity forma-
tion (b, c, red arrow) over stent struts. Abbreviations as in Figure 1.
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Figure 3. Rupture Continued to Lipid Core Behind Covered Stent Struts
A 70-year-old man underwent a 2.5 mm  28 mm SES implantation in the mid-LAD for AMI. Aspirin (100 mg/day) and ticlopidine (200 mg/day) was prescribed
thereafter. Ticlopidine was stopped 6 months after SES implantation. Fifty-nine months after SES implantation, the patient suddenly suffered from recurrence of
angina and was admitted to our hospital. Emergent CAG showed total occlusion at the site of SES (A). After aspiration thrombectomy (B), OCT and CAS was per-
formed. In the distal and proximal portion of stent, OCT and CAS revealed neointimal coverage over stent struts and no stent underexpansion (a). OCT revealed
mixed thrombus, plaque rupture (b), and cavity formation behind neointima-covered stent (c, d, white arrow). CAS revealed ruptured yellow plaque under stent
struts (b, c, yellow arrow). The stent struts were ﬂoating over the ruptured plaque (b, red arrow). Abbreviations as in Figure 1.2
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